Great Novel Therapeutics Biotech & Medicals (7427.TWO)
TWD 37.15
(0.0%)
TWD 37.15
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 26.81 Million TWD | 122.57% |
| 2022 | 12.04 Million TWD | -44.24% |
| 2021 | 21.6 Million TWD | 307.45% |
| 2020 | 5.3 Million TWD | -71.6% |
| 2019 | 18.67 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 29.88 Million TWD | 11.44% |
| 2024 Q2 | 29.88 Million TWD | 0.0% |
| 2023 Q4 | 26.81 Million TWD | 0.0% |
| 2023 FY | 26.81 Million TWD | 122.57% |
| 2023 Q3 | 26.81 Million TWD | -40.59% |
| 2023 Q2 | 45.13 Million TWD | 0.0% |
| 2023 Q1 | 45.13 Million TWD | 274.64% |
| 2022 Q3 | 12.04 Million TWD | 0.0% |
| 2022 FY | 12.04 Million TWD | -44.24% |
| 2022 Q4 | 12.04 Million TWD | 0.0% |
| 2021 FY | 21.6 Million TWD | 307.45% |
| 2020 FY | 5.3 Million TWD | -71.6% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 95.405% |
| Level Biotechnology Inc. | 273.2 Million TWD | 90.186% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 80.545% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 86.422% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 91.453% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 92.72% |
| Visgeneer Inc. | 185.6 Million TWD | 85.554% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 96.342% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 77.63% |
| Neith Corporation | 17.43 Million TWD | -53.806% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -305.153% |
| Enimmune corporation | 173.46 Million TWD | 84.543% |
| TaiRx, Inc. | 60.62 Million TWD | 55.772% |
| EirGenix Inc. | 1.14 Billion TWD | 97.658% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 76.056% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 94.768% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -236.34% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 71.388% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 57.463% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 83.352% |
| RBC Bioscience Corporation | 513.08 Million TWD | 94.774% |
| BiOptic Inc. | 170.56 Million TWD | 84.28% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -283.371% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -15.3% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 97.249% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 97.974% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 98.806% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 78.503% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 97.981% |
| GlycoNex Incorporation | 276.39 Million TWD | 90.299% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 94.79% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -26.321% |
| Lin BioScience, Inc. | 167.73 Million TWD | 84.014% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | 36.399% |
| VBI | 21.25 Million TWD | -26.173% |
| CHO Pharma, Inc. | 110.83 Million TWD | 75.808% |
| NaviFUS Corp. | 53.4 Million TWD | 49.789% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 94.431% |
| Sinew Pharma Inc. | 39.71 Million TWD | 32.485% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 53.802% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 92.643% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 88.224% |
| AP Biosciences Inc | 106.65 Million TWD | 74.859% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 99.24% |
| 3D Global Biotech Inc. | 30.68 Million TWD | 12.607% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 86.319% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 98.263% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 96.905% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -189.058% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | 51.959% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 88.49% |
| TCI GENE Inc. | 155.54 Million TWD | 82.762% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -5.116% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | 41.932% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 91.837% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 58.677% |
| PharmaEngine, Inc. | 91 Million TWD | 70.537% |
| Savior Lifetec Corporation | 457.95 Million TWD | 94.145% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 75.831% |
| OBI Pharma, Inc. | 650.44 Million TWD | 95.878% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 93.139% |
| Acepodia, Inc. | 384.47 Million TWD | 93.026% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 68.659% |